Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Autophagy
|
November 1, 2021
Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells
Yabin Gong, Ning Tang, Panrao Liu, et al.
Journal of Visualized Experiments : Jove
|
June 29, 2026
Bawei Aiguning Granules For Lung Cancer Bone Metastases: A Randomized, Double-blind, Placebo-Controlled Trial Protocol With A Representative Case
Peng Zhao, Yuping Hong, Junli Chang, et al.
Frontiers in Medicine
|
April 4, 2025
Sijunzi decoction granules for the treatment of advanced refractory colorectal cancer: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
Shuchang Nie, Yingyu Su, Lu Lu, et al.
Advanced Healthcare Materials
|
January 27, 2026
A 5-Fluorouracil-Constituted DNA Hydrogel Embedded with Quercetin Remodels Tumor Microenvironment for Robust Chemoimmunotherapy
Yiping Li, Peipei Zhao, Junru Li, et al.
Integrative Cancer Therapies
|
June 22, 2024
Chinese Herbal Medicine Combined With Liuzijue Exercise in Physiological Rehabilitation After Video-assisted Lung Lobectomy for Cancer: A Prospective Propensity Score Matching Study
Ao Qi, Yiyun He, Yifeng Gu, et al.
Frontiers in Pharmacology
|
November 22, 2018
Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial
Qin Wang, Lijing Jiao, Shengfei Wang, et al.
Frontiers in Pharmacology
|
July 24, 2019
Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Lijing Jiao, Jianfang Xu, Jianli Sun, et al.
Biological Procedures Online
|
March 7, 2020
Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Qin Wang, Lijing Jiao, Shengfei Wang, et al.
Scientific Reports
|
April 25, 2017
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients
Lijing Jiao, Changsheng Dong, Jiaxiang Liu, et al.
Integrative Cancer Therapies
|
February 7, 2025
Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study
Yifeng Gu, Yichao Wang, Huiling Zhou, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Autophagy
|
November 1, 2021
Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells
Yabin Gong, Ning Tang, Panrao Liu, et al.
Journal of Visualized Experiments : Jove
|
June 29, 2026
Bawei Aiguning Granules For Lung Cancer Bone Metastases: A Randomized, Double-blind, Placebo-Controlled Trial Protocol With A Representative Case
Peng Zhao, Yuping Hong, Junli Chang, et al.
Frontiers in Medicine
|
April 4, 2025
Sijunzi decoction granules for the treatment of advanced refractory colorectal cancer: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
Shuchang Nie, Yingyu Su, Lu Lu, et al.
Advanced Healthcare Materials
|
January 27, 2026
A 5-Fluorouracil-Constituted DNA Hydrogel Embedded with Quercetin Remodels Tumor Microenvironment for Robust Chemoimmunotherapy
Yiping Li, Peipei Zhao, Junru Li, et al.
Integrative Cancer Therapies
|
June 22, 2024
Chinese Herbal Medicine Combined With Liuzijue Exercise in Physiological Rehabilitation After Video-assisted Lung Lobectomy for Cancer: A Prospective Propensity Score Matching Study
Ao Qi, Yiyun He, Yifeng Gu, et al.
Frontiers in Pharmacology
|
November 22, 2018
Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial
Qin Wang, Lijing Jiao, Shengfei Wang, et al.
Frontiers in Pharmacology
|
July 24, 2019
Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Lijing Jiao, Jianfang Xu, Jianli Sun, et al.
Biological Procedures Online
|
March 7, 2020
Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Qin Wang, Lijing Jiao, Shengfei Wang, et al.
Scientific Reports
|
April 25, 2017
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients
Lijing Jiao, Changsheng Dong, Jiaxiang Liu, et al.
Integrative Cancer Therapies
|
February 7, 2025
Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study
Yifeng Gu, Yichao Wang, Huiling Zhou, et al.
Page
of 7